Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.
Iran denies talks with US after Trump postpones strikes on power grid
Kim Jong Un says North Korea’s nuclear status is irreversible, threatens South
Ukraine's Zelenskyy says Russia preparing new massive attack
Rockets launched from Iraq’s Mosul towards US base in Syria
One killed, 77 hospitalised after Colombian military plane crashes
Hong Kong police given new powers to obtain phone, computer passwords
ICE agents begin deploying at some US airports
Air Canada jet collision shuts LaGuardia; pilots killed, dozens injured
